Form 8-K - Current report:
SEC Accession No. 0001477932-25-005094
Filing Date
2025-07-17
Accepted
2025-07-16 17:47:40
Documents
16
Period of Report
2025-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K thct_8k.htm   iXBRL 8-K 25348
2 ACQUISITION AGREEMENT thct_ex101.htm EX-10.1 288224
3 PRESS RELEASE thct_ex991.htm EX-99.1 19063
  Complete submission text file 0001477932-25-005094.txt   500540

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA thct-20250607.xsd EX-101.SCH 5024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20250607_lab.xml EX-101.LAB 12618
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20250607_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20250607_pre.xml EX-101.PRE 7881
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20250607_def.xml EX-101.DEF 2099
18 EXTRACTED XBRL INSTANCE DOCUMENT thct_8k_htm.xml XML 3411
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55994 | Film No.: 251128257
SIC: 3523 Farm Machinery & Equipment
(CF Office: 06 Technology)